After six months of system development and on-site audits, Dome Life's peptide synthesis platform has passed the medical-grade quality system certification.
The platform adopts high-precision solid-phase synthesis and fully automated purification systems, keeping the purity of main components above 99% with batch-to-batch consistency exceeding industry standards. This certification enables the platform to supply ingredients that directly meet medical-grade requirements for innovative drug companies and diagnostics manufacturers.
Phase II capacity expansion has started, which is expected to triple the current capacity.
